Acyl-CoA synthetase-4, a new regulator of mTOR and a potential therapeutic target for enhanced estrogen receptor function in receptor-positive and -negative breast cancer.
Oncotarget
; 6(40): 42632-50, 2015 Dec 15.
Article
in En
| MEDLINE
| ID: mdl-26536660
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Breast Neoplasms
/
Signal Transduction
/
Receptors, Estrogen
/
Coenzyme A Ligases
/
TOR Serine-Threonine Kinases
Limits:
Animals
/
Female
/
Humans
Language:
En
Journal:
Oncotarget
Year:
2015
Document type:
Article
Affiliation country:
Argentina
Country of publication:
United States